Correlation Between 180 Life and Effector Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 180 Life and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 180 Life and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 180 Life Sciences and Effector Therapeutics, you can compare the effects of market volatilities on 180 Life and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 180 Life with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 180 Life and Effector Therapeutics.

Diversification Opportunities for 180 Life and Effector Therapeutics

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between 180 and Effector is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding 180 Life Sciences and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and 180 Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 180 Life Sciences are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of 180 Life i.e., 180 Life and Effector Therapeutics go up and down completely randomly.

Pair Corralation between 180 Life and Effector Therapeutics

Given the investment horizon of 90 days 180 Life Sciences is expected to generate 2.08 times more return on investment than Effector Therapeutics. However, 180 Life is 2.08 times more volatile than Effector Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  2,147  in 180 Life Sciences on August 28, 2024 and sell it today you would lose (1,925) from holding 180 Life Sciences or give up 89.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy71.47%
ValuesDaily Returns

180 Life Sciences  vs.  Effector Therapeutics

 Performance 
       Timeline  
180 Life Sciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in 180 Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, 180 Life reported solid returns over the last few months and may actually be approaching a breakup point.
Effector Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Effector Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Effector Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

180 Life and Effector Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 180 Life and Effector Therapeutics

The main advantage of trading using opposite 180 Life and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 180 Life position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.
The idea behind 180 Life Sciences and Effector Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios